Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D)

NCT04234867 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped slow recruitment

Conditions

Type 1 Diabetes
Diabetic Ketoacidosis

Interventions

DRUG: Dapagliflozin
DRUG: Placebo oral tablet
OTHER: Stress
OTHER: Placebo Stress

Sponsor

Kinderkrankenhaus auf der Bult